Skip to content

Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy

Efficacy, Tolerability and Long-Term Adherence of a Modified Ketogenic Diet (Atkins) in the Management of Pharmacoresistant Epilepsy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00188500
Enrollment
Unknown
Registered
2005-09-16
Start date
2005-08-31
Completion date
2005-09-30
Last updated
2005-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

epilepsy, atkins diet

Brief summary

The purpose of this study is to determine whether patients with uncontrolled epilepsy can follow a low carbohydrate diet long-term and if so, how will that diet affect their seizures

Detailed description

In the management of drug-resistant epilepsy, many strategies have been examined. The Ketogenic Diet, high in fats and low in all other nutrients was observed to be of benefit. However, due to its complexedness and unpalatability, this diet is rarely used in the adult population. A recent small study showed seizure reduction with the Atkins Diet. In this study, patients will be randomized into one of 2 groups- group 1 receiving limited dietary instruction for the Atkins Diet and group 2- receiving detailed dietary instruction. A seizure severity-matched control group will also take part. We will follow these patients over a period of 2 years looking at seizure frequency, weight, sustainability of the diet, effect on anti-epilepsy medication dosage, effect in cognition, quality of life and financial impact of the diet. Patients will come to clinic to see the dietitian at specific intervals. cognitive testing will also be done at the beginning of the study and every 6 months thereafter. Patients will keep food charts, ketosis charts and seizure diaries.

Interventions

BEHAVIORALatkins diet
BEHAVIORALability to follow low carbohydrate diet

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

medically refractory partial epilepsy financial ability to pay for higher priced food \-

Exclusion criteria

* Low BMI

Design outcomes

Primary

MeasureTime frame
seizure reduction

Secondary

MeasureTime frame
cognitive improvement

Countries

Canada

Contacts

Primary ContactNina Politzer
416 603-5800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026